Atomistry » Sodium » PDB 7icl-7jyc » 7jg3
Atomistry »
  Sodium »
    PDB 7icl-7jyc »
      7jg3 »

Sodium in PDB 7jg3: Human Gar Transformylase in Complex with Gar Substrate and AGF103 Inhibitor

Enzymatic activity of Human Gar Transformylase in Complex with Gar Substrate and AGF103 Inhibitor

All present enzymatic activity of Human Gar Transformylase in Complex with Gar Substrate and AGF103 Inhibitor:
2.1.2.2; 6.3.3.1; 6.3.4.13;

Protein crystallography data

The structure of Human Gar Transformylase in Complex with Gar Substrate and AGF103 Inhibitor, PDB code: 7jg3 was solved by J.Wong-Roushar, C.E.Dann Iii, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 39.54 / 2.09
Space group P 32 2 1
Cell size a, b, c (Å), α, β, γ (°) 74.522, 74.522, 100.06, 90, 90, 120
R / Rfree (%) 18.7 / 23.3

Sodium Binding Sites:

The binding sites of Sodium atom in the Human Gar Transformylase in Complex with Gar Substrate and AGF103 Inhibitor (pdb code 7jg3). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Human Gar Transformylase in Complex with Gar Substrate and AGF103 Inhibitor, PDB code: 7jg3:

Sodium binding site 1 out of 1 in 7jg3

Go back to Sodium Binding Sites List in 7jg3
Sodium binding site 1 out of 1 in the Human Gar Transformylase in Complex with Gar Substrate and AGF103 Inhibitor


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Human Gar Transformylase in Complex with Gar Substrate and AGF103 Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Na1103

b:54.9
occ:1.00
O A:VAL946 2.5 42.4 1.0
O A:HOH1255 2.6 38.4 1.0
O A:VAL904 3.1 43.5 1.0
CE A:MET911 3.2 35.0 1.0
O A:TRP907 3.4 45.2 1.0
C A:VAL946 3.5 44.9 1.0
CG1 A:VAL904 3.5 47.1 1.0
C A:TRP907 3.6 46.2 1.0
CA A:ASN908 3.6 48.6 1.0
N A:ASN908 3.7 50.1 1.0
CB A:VAL946 3.7 38.4 1.0
CB A:MET911 3.7 39.4 1.0
C A:VAL904 3.9 46.8 1.0
O A:HOH1228 4.0 42.9 1.0
CA A:VAL904 4.0 43.9 1.0
CA A:VAL946 4.0 41.6 1.0
CG1 A:VAL946 4.1 38.5 1.0
N A:VAL946 4.3 38.5 1.0
CB A:VAL904 4.3 46.4 1.0
CB A:TRP907 4.4 39.5 1.0
N A:GLY909 4.5 35.0 1.0
CG A:MET911 4.5 42.9 1.0
CA A:TRP907 4.5 43.8 1.0
C A:ASN908 4.5 42.8 1.0
O A:MET911 4.6 37.2 1.0
N A:ALA947 4.6 44.2 1.0
SD A:MET911 4.6 44.5 1.0
N A:MET911 4.7 35.6 1.0
CA A:MET911 4.7 36.7 1.0
CB A:ASN908 4.7 47.0 1.0
OD1 A:ASN908 4.8 50.5 1.0
CG2 A:VAL904 4.9 37.0 1.0
CA A:ALA947 4.9 48.5 1.0
CG2 A:VAL946 5.0 33.2 1.0

Reference:

A.Wallace-Povirk, N.Tong, J.Wong-Roushar, C.O'connor, X.Zhou, Z.Hou, X.Bao, G.E.Garcia, J.Li, S.Kim, C.E.Dann, L.H.Matherly, A.Gangjee. Discovery of 6-Substituted Thieno[2,3-D]Pyrimidine Analogs As Dual Inhibitors of Glycinamide Ribonucleotide Formyltransferase and 5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase in De Novo Purine Nucleotide Biosynthesis in Folate Receptor Expressing Human Tumors Bioorg.Med.Chem. V. 37 16093 2021.
ISSN: ESSN 1464-3391
DOI: 10.1016/J.BMC.2021.116093
Page generated: Mon Aug 18 10:13:27 2025

Last articles

Mn in 9LJU
Mn in 9LJW
Mn in 9LJS
Mn in 9LJR
Mn in 9LJT
Mn in 9LJV
Mg in 9UA2
Mg in 9R96
Mg in 9VM1
Mg in 9P01
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy